TCF12 Knockout HCT 116 Cell Line

TCF12 Knockout HCT 116 Cell Line
Cat.No.:

EDC08350

Species:

Human

Cell Name:

HCT 116

Gene:

TCF12

Gene ID:

6938

Size:

1×10⁶cells

TCF12 Knockout Cell Line (HCT116) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
Cat.No. EDC08350
Product Name TCF12 Knockout HCT 116 Cell Line
Cell Line HCT 116
Cellosaurus ID CVCL_0291
Cell Line Synonyms HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2
Gene TCF12
NCBI Gene ID
Gene Synonyms CRS3|HEB|HH26|HTF4|HsT17266|TCF-12|bHLHb20|p64
Summary
The protein encoded by this gene is a member of the basic helix-loop-helix (bHLH) E-protein family that recognizes the consensus binding site (E-box) CANNTG. This encoded protein is expressed in many tissues, among them skeletal muscle, thymus, B- and T-cells, and may participate in regulating lineage-specific gene expression through the formation of heterodimers with other bHLH E-proteins. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Jul 2008]
Associated Diseases Colorectal Carcinoma
Morphology Adherent
Passage Ratio 1/5-1/4,2days
Complete Culture Medium mcCoy5A+10%FBS
Freezing Medium 90%FBS/Complete culture medium+10% DMSO
QC Indels validated by Sanger sequencing; sterility confirmed via microbial testing.
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
LociSTR Info (Sample Cell)
Sample Cell Line: HCT 116
STR Info (Cell bank)
Cell Line: HCT 116
Allele1Allele2Allele3Allele4Allele1Allele2Allele3Allele4
Amelogenin X X
CSF1PO 7 10 7 9 10 11
D2S1338 16 16
D3S1358 12 17 18 19 12 18 19
D5S818 10 11 10 11
D7S820 11 12 11 12
D8S1179 10 12 14 15 10 12 14 15
D13S317 10 12 10 12
D16S539 11 13 11 12 13 14
D18S51 16 17 16 17
D19S433 12 13 12
D21S11 29 30 29 30
FGA 18 23 18 23
Penta D 9 13 9 13
Penta E 12 13 14 12 13 14
TH01 8 9 8 9
TPOX 8 8
vWA 17 21 22 23 17 21 22 23
D6S1043 13
D12S391 17 21 22
D2S441 11 12
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.

FAQ

The choice depends on whether you are studying TCF12 (HEB) as a class I bHLH transcription factor or its emerging roles in colorectal cancer and stem cell biology. The Knockout line is appropriate for asking whether TCF12 is required for E-box-dependent gene regulation, dimerization with class II bHLH factors, or specific developmental gene programs. Overexpression is useful for testing whether elevated TCF12 is sufficient to alter dimerization partner availability or to drive specific transcriptional programs. Important consideration: TCF12 shares substantial functional overlap with E2A (TCF3) and HEB-T variants — single TCF12 knockout may show modest phenotypes if paralog compensation occurs. The EDITGENE Knockout line in HCT 116 is particularly relevant for colorectal cancer research, where TCF12 has been implicated in EMT and metastasis. Rescue with wild-type, dimerization-deficient, or DNA-binding-deficient TCF12 is the standard approach for dissecting structural contributions to function.
Primary applications: • bHLH dimerization studies: co-immunoprecipitation analysis of TCF12 interactions with class II bHLH partners (MyoD family, E2A, others) and class V Id proteins. • E-box binding: ChIP-qPCR or ChIP-seq for TCF12 occupancy at E-box-containing promoters in the absence of TCF12. • EMT and metastasis: epithelial/mesenchymal marker analysis, migration, and invasion assays relevant to TCF12's reported colorectal cancer roles. • Paralog compensation: E2A (TCF3) expression measurement to assess class I bHLH family redundancy. EDITGENE recommends this model for researchers investigating class I bHLH transcription factors, colorectal cancer EMT, and bHLH-mediated gene regulation.
Yes. TCF12 rescue experiments require attention to dimerization and DNA binding: • Construct design: use a codon-modified TCF12 sequence with a small C-terminal tag (FLAG, HA). TCF12 has multiple alternative splice isoforms — choose the isoform appropriate to the experimental context. • Dimerization-deficient rescue: bHLH domain mutations that disrupt heterodimerization with class II bHLH partners separate DNA-binding from partnership-dependent functions. • DNA-binding-deficient rescue: basic region mutations abolish E-box binding while preserving dimerization, enabling structure-function dissection. • Paralog considerations: E2A (TCF3) expression analysis in rescue cells helps interpret class I bHLH family redundancy. HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation; the MSI-high background should be considered in colorectal cancer context studies.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.

Recommended Accessories

Related Products

Flash CRISPR Knockout Kit(Universal Version)Flash CRISPR Knockout Kit(Universal Version)
Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)

Related Services

Knockout Cell LineKnockout Cell Line
Contact Us
*
*
*
*
How did you hear about us: